Holdings
Fidelity MSCI Health Care Index ETF
As of Jul 31, 2026, Fidelity MSCI Health Care Index ETF reported 326 positions worth US$3.28B. Largest: Eli Lilly and Company, Johnson & Johnson and AbbVie Inc. What it bought and sold, with each filing.
Holdings
- Part of
- Fidelity
- Positions
- 326
- Value as reported
- US$3.28B
- Holdings as of
- Jul 31, 2026
- Last filed
- Sep 23, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Eli Lilly and Company NYSE:LLY | 382K | US$439M | 13.3% | +11,590 | Jul 31, 2026 |
| Johnson & Johnson NYSE:JNJ | 1.15M | US$294M | 8.9% | +35,121 | Jul 31, 2026 |
| AbbVie Inc. NYSE:ABBV | 841K | US$211M | 6.4% | +26,648 | Jul 31, 2026 |
| UnitedHealth Group Incorporated NYSE:UNH | 432K | US$179M | 5.4% | +14,196 | Jul 31, 2026 |
| Merck & Company, Inc. NYSE:MRK | 1.18M | US$153M | 4.7% | +31,927 | Jul 31, 2026 |
| Thermo Fisher Scientific Inc NYSE:TMO | 177K | US$102M | 3.1% | +3,577 | Jul 31, 2026 |
| Amgen Inc. NASDAQ:AMGN | 256K | US$98.8M | 3.0% | +8,201 | Jul 31, 2026 |
| Abbott Laboratories NYSE:ABT | 829K | US$87.6M | 2.7% | +26,907 | Jul 31, 2026 |
| Gilead Sciences, Inc. NASDAQ:GILD | 590K | US$76.9M | 2.3% | +18,510 | Jul 31, 2026 |
| Pfizer, Inc. NYSE:PFE | 2.71M | US$67.7M | 2.1% | +84,892 | Jul 31, 2026 |
| Bristol-Myers Squibb Company NYSE:BMY | 971K | US$63.4M | 1.9% | +32,792 | Jul 31, 2026 |
| CVS Health Corporation NYSE:CVS | 605K | US$63.2M | 1.9% | +19,989 | Jul 31, 2026 |
| Intuitive Surgical, Inc. NASDAQ:ISRG | 169K | US$59.7M | 1.8% | +5,526 | Jul 31, 2026 |
| Danaher Corporation NYSE:DHR | 303K | US$59.1M | 1.8% | +9,934 | Jul 31, 2026 |
| Vertex Pharmaceuticals Incorporated NASDAQ:VRTX | 121K | US$57.7M | 1.8% | +4,041 | Jul 31, 2026 |
| Stryker Corporation NYSE:SYK | 164K | US$53.4M | 1.6% | +5,296 | Jul 31, 2026 |
| Medtronic plc. NYSE:MDT | 611K | US$52.2M | 1.6% | +19,741 | Jul 31, 2026 |
| McKesson Corporation NYSE:MCK | 58,268 | US$49.9M | 1.5% | +1,372 | Jul 31, 2026 |
| Elevance Health, Inc. NYSE:ELV | 104K | US$39.3M | 1.2% | +2,050 | Jul 31, 2026 |
| Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | 49,425 | US$37.7M | 1.1% | +1,809 | Jul 31, 2026 |
| The Cigna Group NYSE:CI | 125K | US$35M | 1.1% | +2,278 | Jul 31, 2026 |
| Boston Scientific Corporation NYSE:BSX | 707K | US$33M | 1.0% | +23,577 | Jul 31, 2026 |
| HCA Healthcare, Inc. NYSE:HCA | 74,445 | US$30M | 0.91% | +806 | Jul 31, 2026 |
| Cencora, Inc. NYSE:COR | 87,910 | US$27.4M | 0.83% | +2,949 | Jul 31, 2026 |
| Cardinal Health, Inc. NYSE:CAH | 112K | US$25.7M | 0.78% | +2,411 | Jul 31, 2026 |
| Edwards Lifesciences Corporation NYSE:EW | 274K | US$23.6M | 0.72% | +6,744 | Jul 31, 2026 |
| Becton, Dickinson and Company NYSE:BDX | 136K | US$22.5M | 0.68% | +4,190 | Jul 31, 2026 |
| IDEXX Laboratories, Inc. NASDAQ:IDXX | 37,781 | US$21.1M | 0.64% | +976 | Jul 31, 2026 |
| Humana Inc. NYSE:HUM | 57,108 | US$20.8M | 0.63% | +1,669 | Jul 31, 2026 |
| IQVIA Holdings, Inc. NYSE:IQV | 80,727 | US$19M | 0.58% | +2,218 | Jul 31, 2026 |
| Agilent Technologies, Inc. NYSE:A | 134K | US$18.6M | 0.57% | +3,745 | Jul 31, 2026 |
| Waters Corporation NYSE:WAT | 46,780 | US$17.7M | 0.54% | +1,445 | Jul 31, 2026 |
| Natera, Inc. NASDAQ:NTRA | 64,051 | US$17.2M | 0.52% | +3,470 | Jul 31, 2026 |
| Zoetis Inc. NYSE:ZTS | 200K | US$15.5M | 0.47% | −3,090 | Jul 31, 2026 |
| DexCom, Inc. NASDAQ:DXCM | 183K | US$15.3M | 0.46% | +3,343 | Jul 31, 2026 |
| GE HealthCare Technologies Inc. NASDAQ:GEHC | 217K | US$14.8M | 0.45% | +7,121 | Jul 31, 2026 |
| ResMed Inc. NYSE:RMD | 69,318 | US$14.6M | 0.44% | +2,029 | Jul 31, 2026 |
| Centene Corporation NYSE:CNC | 234K | US$14.6M | 0.44% | +7,282 | Jul 31, 2026 |
| Illumina, Inc. NASDAQ:ILMN | 70,943 | US$14.6M | 0.44% | +630 | Jul 31, 2026 |
| Revolution Medicines, Inc. NASDAQ:RVMD | 76,953 | US$14.4M | 0.44% | +2,412 | Jul 31, 2026 |
| Veeva Systems Inc. NYSE:VEEV | 69,951 | US$14.3M | 0.43% | −2,042 | Jul 31, 2026 |
| Biogen Inc. NASDAQ:BIIB | 69,831 | US$14.2M | 0.43% | +2,209 | Jul 31, 2026 |
| Mettler-Toledo International, Inc. NYSE:MTD | 9,678 | US$13.7M | 0.42% | +255 | Jul 31, 2026 |
| Alnylam Pharmaceuticals, Inc. NASDAQ:ALNY | 63,090 | US$13M | 0.39% | +2,189 | Jul 31, 2026 |
| Quest Diagnostics Incorporated NYSE:DGX | 52,313 | US$12.2M | 0.37% | +1,035 | Jul 31, 2026 |
| Labcorp Holdings Inc. NYSE:LH | 39,235 | US$12.1M | 0.37% | +1,021 | Jul 31, 2026 |
| West Pharmaceutical Services, Inc. NYSE:WST | 34,263 | US$11.7M | 0.36% | +1,078 | Jul 31, 2026 |
| Royalty Pharma plc NASDAQ:RPRX | 196K | US$11.4M | 0.35% | +8,908 | Jul 31, 2026 |
| STERIS plc (Ireland) NYSE:STE | 46,559 | US$10.6M | 0.32% | +1,277 | Jul 31, 2026 |
| Tenet Healthcare Corporation NYSE:THC | 41,449 | US$10.6M | 0.32% | +991 | Jul 31, 2026 |
| Insmed Incorporated NASDAQ:INSM | 100K | US$9.88M | 0.30% | +1,887 | Jul 31, 2026 |
| Viatris Inc. NASDAQ:VTRS | 555K | US$9.74M | 0.30% | +23,732 | Jul 31, 2026 |
| United Therapeutics Corporation NASDAQ:UTHR | 18,782 | US$9.72M | 0.30% | −70 | Jul 31, 2026 |
| Incyte Corporation NASDAQ:INCY | 80,584 | US$9.63M | 0.29% | +3,729 | Jul 31, 2026 |
| Guardant Health, Inc. NASDAQ:GH | 57,795 | US$9.36M | 0.28% | +5,958 | Jul 31, 2026 |
| Moderna, Inc. NASDAQ:MRNA | 160K | US$8.76M | 0.27% | −2,338 | Jul 31, 2026 |
| Zimmer Biomet Holdings, Inc. NYSE:ZBH | 91,889 | US$8.63M | 0.26% | +456 | Jul 31, 2026 |
| Neurocrine Biosciences, Inc. NASDAQ:NBIX | 45,259 | US$7.55M | 0.23% | −709 | Jul 31, 2026 |
| Roivant Sciences Ltd. NASDAQ:ROIV | 221K | US$7.5M | 0.23% | +47,923 | Jul 31, 2026 |
| Medline Inc. NASDAQ:MDLN | 175K | US$6.89M | 0.21% | New | Jul 31, 2026 |
| The Cooper Companies, Inc. NASDAQ:COO | 92,713 | US$6.71M | 0.20% | +2,375 | Jul 31, 2026 |
| Jazz Pharmaceuticals plc NASDAQ:JAZZ | 26,331 | US$6.66M | 0.20% | +1,159 | Jul 31, 2026 |
| Baxter International Inc. NYSE:BAX | 245K | US$6.41M | 0.19% | +7,045 | Jul 31, 2026 |
| Elanco Animal Health Incorporated NYSE:ELAN | 238K | US$6.27M | 0.19% | +8,136 | Jul 31, 2026 |
| Medpace Holdings, Inc. NASDAQ:MEDP | 10,856 | US$6.27M | 0.19% | +492 | Jul 31, 2026 |
| Solventum Corporation NYSE:SOLV | 70,039 | US$5.98M | 0.18% | −2,145 | Jul 31, 2026 |
| Revvity, Inc. NYSE:RVTY | 53,129 | US$5.98M | 0.18% | +796 | Jul 31, 2026 |
| Exelixis, Inc. NASDAQ:EXEL | 112K | US$5.92M | 0.18% | −5,479 | Jul 31, 2026 |
| Penumbra, Inc. NYSE:PEN | 17,746 | US$5.7M | 0.17% | +594 | Jul 31, 2026 |
| BridgeBio Pharma, Inc. NASDAQ:BBIO | 69,750 | US$5.59M | 0.17% | +3,062 | Jul 31, 2026 |
| Align Technology, Inc. NASDAQ:ALGN | 32,382 | US$5.48M | 0.17% | +944 | Jul 31, 2026 |
| Charles River Laboratories International, Inc. NYSE:CRL | 23,486 | US$5.46M | 0.17% | +812 | Jul 31, 2026 |
| Insulet Corporation NASDAQ:PODD | 32,909 | US$5.44M | 0.17% | +438 | Jul 31, 2026 |
| Bio-Techne Corp NASDAQ:TECH | 74,551 | US$5.37M | 0.16% | +2,714 | Jul 31, 2026 |
| Encompass Health Corporation NYSE:EHC | 47,198 | US$5.24M | 0.16% | +791 | Jul 31, 2026 |
| Corcept Therapeutics Incorporated NASDAQ:CORT | 45,653 | US$5.23M | 0.16% | +1,685 | Jul 31, 2026 |
| BioMarin Pharmaceutical Inc. NASDAQ:BMRN | 84,531 | US$5.07M | 0.15% | +449 | Jul 31, 2026 |
| Molina Healthcare Inc NYSE:MOH | 24,870 | US$4.87M | 0.15% | +1,101 | Jul 31, 2026 |
| The Ensign Group, Inc. NASDAQ:ENSG | 27,229 | US$4.85M | 0.15% | +467 | Jul 31, 2026 |
| Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR | 56,561 | US$4.79M | 0.15% | +11 | Jul 31, 2026 |
| Halozyme Therapeutics, Inc. NASDAQ:HALO | 56,494 | US$4.66M | 0.14% | +2,031 | Jul 31, 2026 |
| Glaukos Corporation NYSE:GKOS | 26,215 | US$4.37M | 0.13% | −235 | Jul 31, 2026 |
| Avantor, Inc. NYSE:AVTR | 313K | US$4.32M | 0.13% | −2,999 | Jul 31, 2026 |
| Globus Medical, Inc. NYSE:GMED | 53,700 | US$4.23M | 0.13% | +1,929 | Jul 31, 2026 |
| BrightSpring Health Services, Inc. NASDAQ:BTSG | 69,119 | US$4.13M | 0.13% | +2,466 | Jul 31, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 18,841 | US$4.11M | 0.12% | +2,764 | Jul 31, 2026 |
| Universal Health Services, Inc. NYSE:UHS | 24,277 | US$4.09M | 0.12% | −1,206 | Jul 31, 2026 |
| Cytokinetics, Incorporated NASDAQ:CYTK | 52,671 | US$4.06M | 0.12% | −1,049 | Jul 31, 2026 |
| HealthEquity, Inc. NASDAQ:HQY | 40,141 | US$4.04M | 0.12% | +797 | Jul 31, 2026 |
| Henry Schein, Inc. NASDAQ:HSIC | 46,652 | US$4M | 0.12% | −2,328 | Jul 31, 2026 |
| Ionis Pharmaceuticals, Inc. NASDAQ:IONS | 74,568 | US$3.86M | 0.12% | +3,590 | Jul 31, 2026 |
| DaVita Inc. NYSE:DVA | 15,871 | US$3.81M | 0.12% | −2,112 | Jul 31, 2026 |
| Alkermes plc NASDAQ:ALKS | 75,274 | US$3.69M | 0.11% | +2,762 | Jul 31, 2026 |
| TG Therapeutics, Inc. NASDAQ:TGTX | 70,188 | US$3.65M | 0.11% | +548 | Jul 31, 2026 |
| Crinetics Pharmaceuticals, Inc. NASDAQ:CRNX | 43,533 | US$3.64M | 0.11% | +2,350 | Jul 31, 2026 |
| Repligen Corporation NASDAQ:RGEN | 24,792 | US$3.5M | 0.11% | +94 | Jul 31, 2026 |
| Praxis Precision Medicines, Inc. NASDAQ:PRAX | 10,917 | US$3.36M | 0.10% | +50 | Jul 31, 2026 |
| Krystal Biotech, Inc. NASDAQ:KRYS | 9,793 | US$3.34M | 0.10% | −183 | Jul 31, 2026 |
| Protagonist Therapeutics, Inc. NASDAQ:PTGX | 24,256 | US$3.31M | 0.10% | +1,124 | Jul 31, 2026 |
| Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL | 7,081 | US$3.31M | 0.10% | +262 | Jul 31, 2026 |
This page holds 100 of 326 positions.